WHO ICTRP trial
This study will help us in understanding how this disease progresses and why…
CTRI/2020/12/029983 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/12/029983 |
|---|---|
| Public title | This study will help us in understanding how this disease progresses and why some became sicker. This study may also help in the development of novel therapy. |
| Scientific title | Characterization of the proteolytic processes in the serum of patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pneumonia- a pilot study |
| Primary sponsor | National Institute of malaria Research New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Control Intervention1: None: None |
| Registration date | Dec 23, 2020 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: